Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
McDermott, D. F., Regan, M. M., Clark, J. I., Flaherty, L. E., Weiss, G. R., Logan, T. F., Kirkwood, J. M., Gordon, M. S., Sosman, J. A., Ernstoff, M. S., Tretter, C. P.G., Urba, W. J., Smith, J. W.,Volume:
23
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2005.03.206
Date:
January, 2005
File:
PDF, 620 KB
english, 2005